Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew F Russo

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Headache|February 12, 2014
Reactive oxygen species induce procalcitonin expression in trigeminal ganglia gliaAnn C Raddant, Andrew F Russo
Science (New York, N.Y.)|July 4, 2024
A new path to migraineAndrew F Russo, Jeffrey J Iliff
Neuropeptides|November 12, 2013
CGRP and migraine: could PACAP play a role too?Eric A Kaiser, Andrew F Russo
Annual Review of Medicine|November 26, 2025
CGRP and Migraine: Real World Insights and Future Therapeutic DirectionsAndrew F Russo, Eric A Kaiser
Expert Opinion on Therapeutic Targets|May 7, 2026
Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later?Adriana Della Pietra, Andrew F Russo
Drug Discovery Today. Therapeutic Strategies|September 29, 2009
CGRP receptor antagonists: A new frontier of anti-migraine medicationsBlanca Marquez de Prado, Andrew F Russo
Endocrinology|December 24, 2005
Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cellsZhongming Zhang, Ian M Dickerson, Andrew F Russo
Handbook of Experimental Pharmacology|January 29, 2019
CGRP in Animal Models of MigraineAnne-Sophie Wattiez, Mengya Wang, Andrew F Russo
The Journal of Headache and Pain|October 15, 2024
Interplay between cannabinoids and the neuroimmune system in migraineErik Zorrilla, Adriana Della Pietra, Andrew F Russo
Cephalalgia : an International Journal of Headache|September 11, 2025
PACAP versus CGRP in migraine: From mouse models to clinical translationAdriana Della Pietra, Adisa Kuburas, Andrew F Russo
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Headache|February 12, 2014
Reactive oxygen species induce procalcitonin expression in trigeminal ganglia gliaAnn C Raddant, Andrew F Russo
Science (New York, N.Y.)|July 4, 2024
A new path to migraineAndrew F Russo, Jeffrey J Iliff
Neuropeptides|November 12, 2013
CGRP and migraine: could PACAP play a role too?Eric A Kaiser, Andrew F Russo
Annual Review of Medicine|November 26, 2025
CGRP and Migraine: Real World Insights and Future Therapeutic DirectionsAndrew F Russo, Eric A Kaiser
Expert Opinion on Therapeutic Targets|May 7, 2026
Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later?Adriana Della Pietra, Andrew F Russo
Drug Discovery Today. Therapeutic Strategies|September 29, 2009
CGRP receptor antagonists: A new frontier of anti-migraine medicationsBlanca Marquez de Prado, Andrew F Russo
Endocrinology|December 24, 2005
Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cellsZhongming Zhang, Ian M Dickerson, Andrew F Russo
Handbook of Experimental Pharmacology|January 29, 2019
CGRP in Animal Models of MigraineAnne-Sophie Wattiez, Mengya Wang, Andrew F Russo
The Journal of Headache and Pain|October 15, 2024
Interplay between cannabinoids and the neuroimmune system in migraineErik Zorrilla, Adriana Della Pietra, Andrew F Russo
Cephalalgia : an International Journal of Headache|September 11, 2025
PACAP versus CGRP in migraine: From mouse models to clinical translationAdriana Della Pietra, Adisa Kuburas, Andrew F Russo
Pageof 10